Journals / BEYOGLU EYE JOURNAL / 2022 / Cilt: 7 - Sayı: 1

The Effect of Fluorosecein on Corneal Endothelial Structure and Morphology in Diabetic Retinopathy Patients undergone Fundus Fluoresecein Angiography

Pages
35–38
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results of this study demonstrated that fluorescein has no toxic effect on corneal endothelium.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To evaluate fluorescein effect on the corneal endothelium by endothelial specular microscopy in diabetic retinopathy patients undergone fundus fluoresecein anjiography (FFA).
📊
Key Findings & Data:Methods: One hundred thirthy four diabetic retinopathy patients undergone FFA aged between 42 and 74 years were included study.
💡
Conclusion & Impact:Conclusion: The results of this study demonstrated that fluorescein has no toxic effect on corneal endothelium.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To evaluate fluorescein effect on the corneal endothelium by endothelial specular microscopy in diabetic retinopathy patients undergone fundus fluoresecein anjiography (FFA). Methods: One hundred thirthy four diabetic retinopathy patients undergone FFA aged between 42 and 74 years were included study. We checked the corneal endothelial cell density (ECD), coefficient of variation of cell area (CV/polymegethism) and percentage of hexagonal cells (6A/pleomorphysm) before FFA and 1 hour, 1 day, 1 week after the procedure. Results: The mean baseline ECD was 2223±216 cells/mm2. The mean ECD before and 1 hour (2234±224 cells/mm2), 1 day (2237±231 cells/mm2), 1 week (2226±219 cells/mm2) after the procedure weren’t significantly different (p=0.243; repeated measure ANOVA). The mean of the coefficient variations of the endothelial cell size before and 1 hour,1 day, 1 week after the procedure were 0.327±0.07, 0.319±0.06, 0.322±0.06, 0.325±0.07 respectively (p=0.281; repeated measure ANOVA). The mean of the baseline percent of hexagonal cells (pleomorphism) in the endothelium was 61.7±5.2, and the postoperative 1 hour, 1 day, 1 week percent were 62.3±5.7, 61.9±6.1, 61.3±5.9, respectively (p= 0.317; repeated measure ANOVA). Conclusion: The results of this study demonstrated that fluorescein has no toxic effect on corneal endothelium.

🔖

Cite This Article

ÇALLI, U., ÖZTÜRK, Y., DEMİR, G. (2022). The Effect of Fluorosecein on Corneal Endothelial Structure and Morphology in Diabetic Retinopathy Patients undergone Fundus Fluoresecein Angiography. BEYOGLU EYE JOURNAL, Cilt: 7 - Sayı: 1, 35–38. https://ajindex.com/articles/649061

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Goldmann H. Fluorescein in the anterior chamber; the minute volume of the human aqueous humor. Ophthalmologica 1950;119:65–95
  2. Kinsey VE, Palm E. Posterior and anterior chamber aqueous humor formation. Arch Ophthalmol 1955;53:330–44
  3. Knudsen LL, Olsen T, Nielsen-Kudsk F. Anterior chamber fluorescein kinetics compared with vitreous kinetics in normal subjects. Acta Ophthalmol Scand 1998;76:561–7
  4. Moses RA. Adler’s physiology of the eye. The C.V. St. Louis (MO): Mosby Company; 1955
  5. Knudsen LL, Nielsen-Kudsk F. Anterior chamber and vitreous fluorescein kinetics in normal and diabetic subjects. Acta Ophthalmol Scand 1998;76:396–400 6. Perry HD, Foulks GN, Thoft RA, Tolentino FI. Corneal complications after closed vitrectomy through the pars plana. Arch Ophthalmol 1978;96:1401–3
  6. Michels RG, Ryan SJ. Results and complications of 100 consecutive cases of pars plana vitrectomy. Am J Ophthalmol 1975;80:24–9
  7. Lass JH, Spurney RV, Dutt RM, Andersson H, Kochar H, Rodman HM, et al. A morphologic and fluorophotometric analysis of the corneal endothelium in type I diabetes mellitus and cystic fibrosis. Am J Ophthalmol 1985;100:783–8
  8. Busted N, Olsen T, Schmitz O. Clinical observations on the corneal thickness and the corneal endothelium in diabetes mellitus. Br J Ophthalmol 1981;65:687–90
  9. Herse P, Hooker B. Corneal edema recovery dynamics in diabetes: is the alloxan induced rabbit a useful model? Invest Ophthalmol Vis Sci 1994;35:310–3
  10. Schultz RO, Matsuda M, Yee RW, Edelhauser HF, Schultz KJ. Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol 1984;98:401–10
  11. Keoleian GM, Pach JM, Hodge DO, Trocme SD, Bourne WM. Structural and functional studies of the corneal endothelium in diabetes mellitus. Am J Ophthalmol 1992;11:64–70
  12. Itoi M, Nakamura T, Mizobe K, Kodama Y, Nakagawa N, Itoi M. Specular microscopic studies of the corneal endothelia of Japanese diabetics. Cornea 1989;8:2–6
  13. Matsuda M, Ohguro N, Ishimoto I, Fukuda M. Relationship of corneal endothelial morphology to diabetic retinopathy, duration of diabetes and glycemic control. Jpn J Ophthalmol 1990;34:53–6
  14. Watsky MA, McDermott ML, Edelhauser HF. In vitro corneal endothelial permeability in rabbit and human: the effects of age, cataract surgery and diabetes. Exp Eye Res 1989;49:751–67
  15. Larsson LI, Bourne WM, Pach JM, Brubaker RF. Structure and function of the corneal endothelium in diabetes mellitus type I and type II. Arch Oph